{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-048469","form_type":"8-K","ticker":"ARQT","cik":"0001787306","company_name":"Arcutis Biotherapeutics, Inc.","filed_at":"2026-07-16T20:25:02+00:00","discovered_at":"2026-07-16T20:26:00.318667+00:00","generated_at":"2026-07-16T20:26:05.562467+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Arcutis appoints Christopher Peetz to Board of Directors","bullets":["Christopher Peetz appointed as Class III director effective July 15, 2026; term expires at 2029 annual meeting.","Peetz is co-founder and CEO of Mirum Pharmaceuticals; brings biopharma leadership and M&A experience.","Received initial option for 21,486 shares; eligible for prorated annual equity (~$350K) and $50K cash retainer.","Board determined Peetz qualifies as independent under SEC and Nasdaq rules; no committee assignment yet.","Appointment expands board from nine to ten members; no family or material transaction relationships disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-048469","json":"https://secwatch.observer/filing/0001628280-26-048469.json","markdown":"https://secwatch.observer/filing/0001628280-26-048469.md","text":"https://secwatch.observer/filing/0001628280-26-048469.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1787306/000162828026048469/0001628280-26-048469-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1787306/000162828026048469/arqt-20260715.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-16T20:26:05.562467+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}